<em>Regardless the success gained in treatment of acute lymphoblastic leukaemia, several problems still remain to be solved, such as: overcoming primary drug resistance and minimizing the amount of relapses as well as decreasing of chemotherapy toxicity without detriment to the final outcome of the treatment. Development of an optimal chemotherapeutical strategy still remains a hot issue. Objective: to evaluate an efficacy of two modifications of German protocol COALL-92 in treatment of ALL in children in St.-Petersburg. Methods: the retrospective analysis of results of treatment in patients under 18 years old with ALL was performed. The diagnosis was confirmed according to international criteria. The treatment was performed via protocols P...
Background: Childhood acute lymphoblastic leukemia (ALL) represents the largest group of pediatric m...
We analyzed the long-term outcome of 4865 patients treated in Studies 82, 87, 88, 91 and 95 for chil...
BackgroundAcute lymphoblastic leukaemia (ALL) represents about 30% of cancer in children and thus is...
<p>Treatment results in children with acute lymphoblastic leukemia (ALL) treating in St.-Petersburg ...
The article presents the results of the treatment of children with acute lymphoblast leukemia (all) ...
The article demonstrates the treatment results on the protocol the treatment of children with acute ...
Treatment of acute lymphoblastic leukemia (ALL) in children during the last 50 years has changed sig...
Background and objective: Because of the need for more comprehensive information on the least toxic ...
Artículo de publicación ISIPurpose From 2002 to 2007, the International Berlin-Frankfurt-Mu¨ nster ...
Dramatic progress in the treatment of childhood acute lymphoblastic leukemia (ALL) has been achieved...
In The Netherlands from July 1988 to October 1991, children (0 to 16 years of age) with de novo acut...
In The Netherlands from July 1988 to October 1991, children (0 to 16 years of age) with de novo acut...
Thirty-nine consecutive patients with acute lymphoblastic leukemia were treated with an intensive ch...
Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood. Despite enormous impr...
PURPOSE: From 2002 to 2007, the International Berlin-Frankfurt-Munster Study Group conducted a prosp...
Background: Childhood acute lymphoblastic leukemia (ALL) represents the largest group of pediatric m...
We analyzed the long-term outcome of 4865 patients treated in Studies 82, 87, 88, 91 and 95 for chil...
BackgroundAcute lymphoblastic leukaemia (ALL) represents about 30% of cancer in children and thus is...
<p>Treatment results in children with acute lymphoblastic leukemia (ALL) treating in St.-Petersburg ...
The article presents the results of the treatment of children with acute lymphoblast leukemia (all) ...
The article demonstrates the treatment results on the protocol the treatment of children with acute ...
Treatment of acute lymphoblastic leukemia (ALL) in children during the last 50 years has changed sig...
Background and objective: Because of the need for more comprehensive information on the least toxic ...
Artículo de publicación ISIPurpose From 2002 to 2007, the International Berlin-Frankfurt-Mu¨ nster ...
Dramatic progress in the treatment of childhood acute lymphoblastic leukemia (ALL) has been achieved...
In The Netherlands from July 1988 to October 1991, children (0 to 16 years of age) with de novo acut...
In The Netherlands from July 1988 to October 1991, children (0 to 16 years of age) with de novo acut...
Thirty-nine consecutive patients with acute lymphoblastic leukemia were treated with an intensive ch...
Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood. Despite enormous impr...
PURPOSE: From 2002 to 2007, the International Berlin-Frankfurt-Munster Study Group conducted a prosp...
Background: Childhood acute lymphoblastic leukemia (ALL) represents the largest group of pediatric m...
We analyzed the long-term outcome of 4865 patients treated in Studies 82, 87, 88, 91 and 95 for chil...
BackgroundAcute lymphoblastic leukaemia (ALL) represents about 30% of cancer in children and thus is...